Cowealth Medical China Co.,Ltd. (SHA:603122)

Cowealth Medical China Statistics

Total Valuation

SHA:603122 has a market cap or net worth of CNY 5.19 billion. The enterprise value is 5.03 billion.

Market Cap	5.19B
Enterprise Value	5.03B

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	Jul 14, 2025

Share Statistics

SHA:603122 has 398.05 million shares outstanding. The number of shares has increased by 11.07% in one year.

Current Share Class	398.05M
Shares Outstanding	398.05M
Shares Change (YoY)	+11.07%
Shares Change (QoQ)	+16.38%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	2.49%
Float	173.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.68
PB Ratio	4.69
P/TBV Ratio	4.72
P/FCF Ratio	23.37
P/OCF Ratio	21.60
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-441.94
EV / Sales	6.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	22.63

Financial Position

The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.02.

Current Ratio	3.13
Quick Ratio	2.36
Debt / Equity	0.02
Debt / EBITDA	8.21
Debt / FCF	0.12
Interest Coverage	-18.71

Financial Efficiency

Return on equity (ROE) is -0.94% and return on invested capital (ROIC) is -0.39%.

Return on Equity (ROE)	-0.94%
Return on Assets (ROA)	-0.31%
Return on Invested Capital (ROIC)	-0.39%
Return on Capital Employed (ROCE)	-0.67%
Revenue Per Employee	3.83M
Profits Per Employee	-56,018
Employee Count	203
Asset Turnover	0.52
Inventory Turnover	3.35

Taxes

Income Tax	-1.46M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.68% in the last 52 weeks. The beta is 0.70, so SHA:603122's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+22.68%
50-Day Moving Average	7.15
200-Day Moving Average	7.02
Relative Strength Index (RSI)	95.05
Average Volume (20 Days)	15,683,024

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:603122 had revenue of CNY 777.03 million and -11.37 million in losses. Loss per share was -0.03.

Revenue	777.03M
Gross Profit	121.59M
Operating Income	-7.49M
Pretax Income	-12.16M
Net Income	-11.37M
EBITDA	-441,168
EBIT	-7.49M
Loss Per Share	-0.03

Balance Sheet

The company has 193.20 million in cash and 25.94 million in debt, giving a net cash position of 167.25 million or 0.42 per share.

Cash & Cash Equivalents	193.20M
Total Debt	25.94M
Net Cash	167.25M
Net Cash Per Share	0.42
Equity (Book Value)	1.11B
Book Value Per Share	2.19
Working Capital	875.22M

Cash Flow

In the last 12 months, operating cash flow was 240.36 million and capital expenditures -18.28 million, giving a free cash flow of 222.08 million.

Operating Cash Flow	240.36M
Capital Expenditures	-18.28M
Free Cash Flow	222.08M
FCF Per Share	0.56

Margins

Gross margin is 15.65%, with operating and profit margins of -0.96% and -1.46%.

Gross Margin	15.65%
Operating Margin	-0.96%
Pretax Margin	-1.56%
Profit Margin	-1.46%
EBITDA Margin	-0.06%
EBIT Margin	-0.96%
FCF Margin	28.58%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 1.10%.

Dividend Per Share	0.13
Dividend Yield	1.10%
Dividend Growth (YoY)	116.67%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.07%
Shareholder Yield	-9.86%
Earnings Yield	-0.22%
FCF Yield	4.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2